Senseonics Holdings SENS
NASDAQ SENS
$8.94 -0.16 (-1.81%)
At close: Aug 20, 2026 · 2:22 PM UTC

Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026)

Senseonics Holdings (SENS) posted quarterly Liabilities and Shareholders Equity of $102.9 million for Q1 2026, up 17.94% year-over-year from $87.2 million in Q1 2025, and down 18.54% quarter-over-quarter from $126.3 million in Q4 2025.

Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has reported Liabilities and Shareholders Equity for 13 consecutive years, with $102.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 17.94% year-over-year to $102.9 million; the TTM figure through Mar 2026 stood at $519.3 million (up 31.29% YoY), while the FY2025 annual figure was $126.3 million, up 25.72% from the prior year.
  • Liabilities and Shareholders Equity fell to $102.9 million in Q1 2026 per SENS's latest filing, from $126.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $188.1 million in Q1 2022 and bottomed at $87.2 million in Q1 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $139.4 million across 5 years, with a median of $139.9 million in 2025.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity sank 37.47% — and 2025, when it surged 45.25%.
  • Senseonics Holdings' Liabilities and Shareholders Equity stood at $177.7 million in 2022, then fell by 22.21% to $138.2 million in 2023, then fell by 27.33% to $100.4 million in 2024, then climbed by 25.72% to $126.3 million in 2025, then decreased by 18.54% to $102.9 million in 2026.
  • Business Quant data shows SENS's Liabilities and Shareholders Equity at $102.9 million in Q1 2026, $126.3 million in Q4 2025, and $139.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn 109.22 Bn
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 31.04 Bn
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn 10.74 Bn
10 Senseonics Holdings 517.40 Mn 276.80 Mn 8.56 Mn 176.84 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 176.84 Mn
Mar 31, 2026 102.86 Mn
Dec 31, 2025 126.27 Mn
Sep 30, 2025 139.92 Mn
Jun 30, 2025 150.27 Mn
Mar 31, 2025 87.21 Mn
Dec 31, 2024 100.44 Mn
Sep 30, 2024 96.33 Mn
Jun 30, 2024 111.56 Mn
Mar 31, 2024 126.52 Mn
Dec 31, 2023 138.22 Mn
Sep 30, 2023 154.07 Mn
Jun 30, 2023 153.36 Mn
Mar 31, 2023 158.53 Mn
Dec 31, 2022 177.67 Mn
Sep 30, 2022 182.67 Mn
Jun 30, 2022 175.33 Mn
Mar 31, 2022 188.10 Mn
Dec 31, 2021 198.93 Mn
Sep 30, 2021 219.62 Mn